Thu 25 Jun 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| (LUMINOUS)Study to observe the effectiveness andsafety of ranibizumab through individualized patienttreatment and associated | Novartis | Ongoing | Ranibizumab 10mg/ml (Lucentis) | 4 | FB002A2406 | King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah) , Prince Sultan Military Medical City (Riyadh) |
| Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial | King Saud Medical City | Ongoing | Colistin | 4 | CCD-AFM-00 | King Saud Medical City (Riyadh) |
| Dyslipidemia International Study II: Lipid target achievement in high risk patients with Acute Coronary Syndrome (DYSIS II) | MSD | Ongoing | N/A | 4 | 0653A 427 | Riyadh Care Hospital (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh) |
| Glargine Insulin versus Continuous Regular Insulin in Diabetic Surgical Patients Receiving Total Parenteral Nutrition | King Faisal Specialist Hospital & Research Center | Ongoing | Lantus® | 4 | 147 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A multicenter, observational, prospective Study of theuse of Valsartan (Tabuvan®) and Valsartan HCTZ (co-Tabuvan®) on adult patients with essentialHypertension in Saudi Arabia | Tabuk Pharmaceuticals | Ongoing | Tabuvan | 4 | T-VAHST | Prince Sultan Military Medical City (Riyadh) |
| Multi-Center Prospective Randomized Controlled Trial of Intracranial Pressure Monitoring in Patients with Severe Traumatic Brain Injury | KAIMRC | Ongoing | N/A | 4 | RC11/056 | King Abdulaziz Medical City NG (Riyadh) |
| A randomised blinded placebo controlled trial of hydrocortisone in critically illpatients with septic shock | University of Sydney | Ongoing | HYDROCORTISONE | 4 | GI-CCT3722 | King Fahad Medical City (riyadh), King Khalid University Hospital (Riyadh) |
| LUMINOUS™: Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes | Novartis | Ongoing | RANIBIZUMAB | 4 | RFB002A240 | king khaled eye specialist hospital (riyadh) |
| The Effect of Caffeine on the Narcoleptic Patients Randomized Controlled Clinical Trial | King Saud University | Ongoing | Caffeine | 4 | E-15-1484 | King Khalid University Hospital (Riyadh) |
| Alx-Mcd-502 A Natural History Study Of Molybdenum Cofactor And Isolated Sulfite Oxidase Deficiencies | Alexion Pharma International Sàrl. | Completed | N/A | 4 | ALX-MCD-502 | King Fahad Medical City (Riyadh) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.